Release Date: 05/11/14 11:58 Summary: Change in substantial holding from CBA Price Sensitive: No Download Document 1.94MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%